Maynard Um
-
-
-
-
-
-
-
Ultragenyx Pharma (RARE) PT Lowered to $33 at Cantor Fitzgerald
-
-
-
-
-
-
-
After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
-
-
-
-
-
-
-
Ultragenyx Pharma (RARE) Tops Q2 EPS by 32c ; Offers Guidance
-
-
-
-
-
-
-
Ultragenyx receives FDA clearance for GNE myopathy drug trial
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Ultragenyx Pharma (RARE)
-
-
-
-
-
-
-
Ultragenyx completes gene therapy application for rare metabolic disease
-
-
-
-
-
-
-
TD Cowen Reiterates Buy Rating on Ultragenyx Pharma (RARE)
-
445,774 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

